Literature DB >> 19489862

Oesophagitis dissecans superficialis: an acute, benign phenomenon associated with pemphigus vulgaris.

W G G Cesar1, M M Barrios, C W Maruta, V Aoki, G G Santi.   

Abstract

Pemphigus vulgaris (PV) is an autoimmune dermatosis that may evolve to severely compromise the skin and/or mucosa. Autoantibodies directed against epithelial cadherins, such as desmogleins 1 and 3, lead to acantholysis and culminate in blister formation. Involvement of the oral mucosa is common, but other squamous stratified epithelia may also be the target of the autoimmune aggression. We report a woman with PV that was in partial remission, who developed an unusual acute phenomenon, known as oesophagitis dissecans superficialis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19489862     DOI: 10.1111/j.1365-2230.2009.03308.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A review.

Authors:  Akira Hokama; Yu-Ichi Yamamoto; Kiyohito Taira; Mitsuteru Nakamura; Chiharu Kobashigawa; Manabu Nakamoto; Tetsuo Hirata; Nagisa Kinjo; Fukunori Kinjo; Kenzo Takahashi; Jiro Fujita
Journal:  World J Gastrointest Endosc       Date:  2010-07-16

Review 2.  Esophagitis dissecans superficialis: a case report and literature review.

Authors:  Shumona De; Geoffrey S Williams
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

3.  Esophagitis Dissecans Superficialis: Clinical, Endoscopic, and Histologic Features.

Authors:  Phil A Hart; Ryan C Romano; Roger K Moreira; Karthik Ravi; Seth Sweetser
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

4.  Sloughing esophagitis: a not so common entity.

Authors:  Hossein Akhondi
Journal:  Int J Biomed Sci       Date:  2014-12

5.  The Clinical Course and Management of Severe Esophagitis Dissecans Superficialis: A Case Report.

Authors:  Isaac Jaben; Richard Schatz; Ira Willner
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.